A. Lew et Ar. Chamberlin, Blockers of human T cell Kv1.3 potassium channels using de novo ligand design and solid-phase parallel combinatorial chemistry, BIOORG MED, 9(23), 1999, pp. 3267-3272
Blockers of the human Kv1.3 potassium channel were designed using Biosym/MS
I's ligand design program LUDI. Parallel combinatorial synthesis of the res
ultant substituted phenyl-stilbenes on solid phase, followed by I-125 Chary
bdotoxin (I-125 ChTx) screening, yielded 12 Kv1.3 channel blockers with mod
est activity. (C) 1999 Elsevier Science Ltd. All rights reserved.